Background: Aortic intima-media thickness (aIMT) measurement is an established indicator of preclinical atherosclerosis. We aimed to describe the aIMT and its determinants in newborns with congenital heart disease (CHD) undergoing cardiac surgery.
CREATINE AS A TREATMENT FOR HYPOXIC-INDUCED
Background: The high metabolic activity of the placenta is maintained by increasing mitochondrial activity with advancing gestation. Hypoxia damages these processes, leading to placental dysfunction and fetal demise. This in vitro study assessed whether creatine supplementation could enhance placental mitochondrial activity and ATP homeostasis, during hypoxia.
Methods: Primary cytotrophoblasts were isolated from healthy term placentas (n=5) and cultured for 48 h in normoxia (8% O 2 , 5% CO 2 , 37 C), with or without 5mM creatine media. Cells were then exposed to hypoxia (1% O 2 , 5% CO 2 , 37 C) for 24 h. Controls were maintained in normoxia. Cell viability was assessed by MTS assay. Live cells were stained with TMRM and MitoTacker Deep Red (MTDR), to assess changes in mitochondrial membrane potential (MMP). Mitochondrial respiration was also assessed using the Seahorse Mito Stress Test XF assay (Agilent), with results normalized to total protein. All data was analysed by one-way ANOVA with Tukey's multiple comparisons.
Results: Creatine treatment significantly improved cell viability under hypoxic conditions (+15%, P < 0.01). TMRM/MTDR ratio, indicative of intact MMP was also improved in hypoxic cells pre-treated with creatine (P < 0.01). Overall, creatine treatment of normoxic cells improved mitochondrial respiration, leading to significant differences in basal respiration (P = 0.01), maximal respiration (P = 0.02) and spare respiratory capacity (P=0.01), when compared to control hypoxic cells. Under hypoxic conditions, creatine treatment had no significant impact on mitochondrial respiratory measures, although, a trend to improve basal respiration and ATP production was observed.
Conclusion: Creatine treatment improved overall cell viability and prevented hypoxic-induced mitochondrial structural derangement by maintaining MMP. Background: Preterm infants are often unable to co-ordinate sucking, swallowing and breathing reflexes for oral feeding, so initial nutrition is provided by tube feeding. During tube feeds, milk bypasses the nasal and oral cavities where sensory perception of smell and taste occurs. Smell and taste trigger cerebral activation of physiological pre-absorptive processes that contribute to food digestion and absorption, potentially assisting with tolerance of feeds.
EXPOSURE TO THE SMELL AND TASTE OF MILK TO ACCELERATE FEEDING IN PRETERM INFANTS: COCHRANE SYSTEMATIC REVIEW
Methods: The standard Cochrane Neonatal search strategy was used to identify published and ongoing randomised and quasi-randomised trials comparing exposure to smell and/or taste of milk during tube feeds with no exposure in preterm infants. Primary outcome was time required to reach full sucking feeds. Fixed-effects models were used for meta-analysis.
Results: Two trials involving 131 preterm infants were identified. Very low-quality evidence demonstrated that exposure to smell and taste of milk with tube feeds decreased length of hospitalisation (mean difference −3.9 days, 95% Confidence Intervals −7.0 to 0.8 days). There was no clear effect of the intervention on time to reach full tube feeding, duration of parenteral nutrition, incidence of late infection, necrotising enterocolitis, time to reach full sucking feeds and growth. No data were available to assess potential adverse effects, feed intolerance and rates of exclusive breastfeeding.
Conclusions: Exposure to smell and taste of milk during tube feeds may be beneficial, but there is not enough evidence to
